CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-31 | Rice Derica W Director | Grant or award · Deferred Share Units | +614.86 | $60.99 | $38K | 31,296.03 |
| 2025-03-31 | McMullen Michael R. Director | Grant or award · Deferred Share Units | +512.38 | $60.99 | $31K | 8,339.08 |
| 2025-03-31 | Arduini Peter J Director | Grant or award · Deferred Share Units | +553.37 | $60.99 | $34K | 61,491.29 |
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise | +1,165 | 12,480 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Other disposition | −80 | 12,400 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Shares withheld for taxes | −482 | $63.11 | $30K | 11,918 |
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise | +1,107 | 13,025 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Other disposition | −193 | 12,832 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Shares withheld for taxes | −406 | $63.11 | $26K | 12,426 |
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise | +2,342 | 14,768 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Other disposition | −399 | 14,369 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Shares withheld for taxes | −862 | $63.11 | $54K | 13,507 |
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise | +6,641 | 20,148 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Other disposition | −2,449 | 17,699 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Shares withheld for taxes | −1,860 | $63.11 | $117K | 15,839 |
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise · Market Share Units | −1,165 | 0 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise · Market Share Units | −1,107 | 1,107 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise · Market Share Units | −2,342 | 4,684 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Grant or award · Market Share Units | +23,431 | 23,431 | ||
| 2025-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise · Performance Shares | −6,641 | 0 |
Page 16 of 40 · 799 trades